| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS10052933 | HBV | ENSG00000171552.14 | protein_coding | BCL2L1 | No | No | 598 | A0A0S2Z3C5 Q07817 Q5TE63 |
| TVIS30020598 | HIV | ENSG00000171552.14 | protein_coding | BCL2L1 | No | No | 598 | A0A0S2Z3C5 Q07817 Q5TE63 |
| TVIS30053238 | HIV | ENSG00000171552.14 | protein_coding | BCL2L1 | No | No | 598 | A0A0S2Z3C5 Q07817 Q5TE63 |
| TVIS20005280 | HPV | ENSG00000171552.14 | protein_coding | BCL2L1 | No | No | 598 | A0A0S2Z3C5 Q07817 Q5TE63 |
| TVIS20014967 | HPV | ENSG00000171552.14 | protein_coding | BCL2L1 | No | No | 598 | A0A0S2Z3C5 Q07817 Q5TE63 |
| TVIS20014968 | HPV | ENSG00000171552.14 | protein_coding | BCL2L1 | No | No | 598 | A0A0S2Z3C5 Q07817 Q5TE63 |
| TVIS20014969 | HPV | ENSG00000171552.14 | protein_coding | BCL2L1 | No | No | 598 | A0A0S2Z3C5 Q07817 Q5TE63 |
| TVIS44006307 | HTLV-1 | ENSG00000171552.14 | protein_coding | BCL2L1 | No | No | 598 | A0A0S2Z3C5 Q07817 Q5TE63 |
| TVIS44051628 | HTLV-1 | ENSG00000171552.14 | protein_coding | BCL2L1 | No | No | 598 | A0A0S2Z3C5 Q07817 Q5TE63 |
| TVIS43000121 | MCV | ENSG00000171552.14 | protein_coding | BCL2L1 | No | No | 598 | A0A0S2Z3C5 Q07817 Q5TE63 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | BCL2L1 |
|---|---|
| DrugBank ID | DB13044 |
| Drug Name | Gossypol |
| Target ID | BE0003510 |
| UniProt ID | Q07817 |
| Regulation Type | |
| PubMed IDs | 16020667 |
| Citations | Bauer JA, Trask DK, Kumar B, Los G, Castro J, Lee JS, Chen J, Wang S, Bradford CR, Carey TE: Reversal of cisplatin resistance with a BH3 mimetic, (-)-gossypol, in head and neck cancer cells: role of wild-type p53 and Bcl-xL. Mol Cancer Ther. 2005 Jul;4(7):1096-104. |
| Groups | Investigational |
| Direct Classification | Sesquiterpenoids |
| SMILES | CC(C)C1=C2C=C(C)C(=C(O)C2=C(C=O)C(O)=C1O)C1=C(O)C2=C(C=O)C(O)=C(O)C(C(C)C)=C2C=C1C |
| Pathways | |
| PharmGKB | |
| ChEMBL | CHEMBL51483 |
